327 studies found for:    glioblastoma | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
Condition: Glioblastoma
Intervention: Other: Platelet level determination
22 Not yet recruiting Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
Conditions: Glioblastoma;   Glioblastoma Multiforme;   Gliosarcoma;   Brain Neoplasms;   Central Nervous System Neoplasms
Interventions: Drug: topotecan;   Drug: pazopanib
23 Not yet recruiting Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
Conditions: Glioblastoma;   Glioblastoma Multiforme
Interventions: Drug: 5-day TMZ;   Drug: 21-day TMZ;   Biological: PEP-CMV;   Drug: Tetanus-Diphtheria booster;   Drug: Tetanus Pre-Conditioning
24 Recruiting Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
Conditions: Adult Brain Glioblastoma;   Glioblastoma Multiforme
Interventions: Biological: SL-701; poly-ICLC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethyl cellulose);   Drug: Bevacizumab
25 Recruiting Biomarkers for Prognosis of Glioblastoma (GBM)
Condition: Glioblastoma
Intervention:
26 Recruiting Surgery for Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Procedure: Surgery followed by adjuvant second-line therapy;   Procedure: Second-line therapy alone
27 Recruiting A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
Condition: Glioblastoma
Intervention: Drug: Bevacizumab 25 mg in 1 ml subcutaneously daily
28 Recruiting ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: ABT-414;   Drug: Lomustine;   Drug: Temozolomide
29 Unknown  Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
Conditions: Glioblastomas;   Gliosarcoma
Intervention: Other: Hyperbaric Oxygen Therapy
30 Recruiting Prevention of Thrombocytopenia in Glioblastoma Patients
Conditions: Thrombocytopenia,;   Glioblastoma
Intervention: Drug: Romiplostim
31 Recruiting Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: TPI 287;   Drug: Bevacizumab
32 Recruiting Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma
Conditions: Glioblastoma;   Glioma
Intervention: Drug: Ribociclib
33 Recruiting FMISO PET Study of Glioblastoma
Condition: Recurrent Glioblastoma
Interventions: Device: FMISO PET;   Device: MRI;   Drug: Bevacizumab;   Drug: CCNU
34 Recruiting O6-Benzylguanine and Temozolomide With MGMTP140K Genetically Modified Blood Stem Cells in Untreated Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Biological: MGMTP140K-encoding retroviral vector;   Drug: O6-benzylguanine;   Drug: temozolomide;   Other: laboratory biomarker analysis;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Radiation: radiation therapy
35 Recruiting Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioblastoma
Conditions: Glioblastoma;   Astrocytoma
Intervention: Radiation: Rhenium Liposome Treatment
36 Recruiting A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Biological: ICT-121 DC vaccine
37 Recruiting Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Biological: anti-EGFRvIII CAR T cells;   Drug: cyclophosphamide;   Drug: Fludarabine
38 Recruiting Neoadjuvant Nivolumab in Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: Nivolumab
39 Unknown  Procarbazine and Lomustine in Recurrent Glioblastoma
Condition: Recurrent Glioblastoma Multiforme
Intervention: Drug: lomustine and procarbazine
40 Recruiting Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
Condition: Glioblastoma
Interventions: Biological: ALECSAT;   Radiation: radiotherapy;   Drug: Temozolomide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years